Dr. Michael Majerus
- Nationality: German
Dr. Michael Majerus, born 1961 in Cologne, studied business administration at the University of Cologne and graduated with a degree in business administration. After completing his doctorate in economics at the University of Siegen in 1989, he began his career in controlling at Mannesmann AG. In the following years, he held various management positions in the Mannesmann Group’s finance department. From 1999 to 2000, he was responsible as the central divisional head of controlling and accounting. Following the takeover of the Mannesmann Group by Vodafone, Dr. Majerus worked in the same function for the industrial companies grouped under ATECS Mannesmann AG.
From the end of 2000 to 2006, he was a member of the Management Board and CFO of the Memory Products Division of Infineon Technologies AG. When the division became legally independent as Qimonda AG in 2006, he was appointed the company’s CFO and employee relations director, and implemented the company’s IPO in New York. After leaving Qimonda AG, he became a member of the Management Board (CFO) of PHOENIX Pharmahandel GmbH & Co KG from 2009 to 2013.
In July 2014, he assumed the position of Chief Financial Officer of SGL Carbon SE, a position he held until November 2020. In addition to that, he led the company as Spokesman of the Board of Management from September 2019 to May 2020. Dr. Majerus is a shareholder of Neofon GmbH and has held a number of positions on the Supervisory Board or similar bodies of companies in several European countries as well as the USA, China and Taiwan over the last 20 years.
Dr. Majerus has been a member of the BRAIN Biotech AG Supervisory Board since March 7, 2019 and is elected until the end of the AGM in FY 2026/27
Further memberships of statutory Supervisory Boards in Germany:
- Deputy Chairman of the Supervisory Board of Team Neusta AG, Bremen
Further memberships in comparable German and foreign Supervisory Boards:
- None
Independent within the meaning of Section C.6, C.7 and C.9 of the German Corporate Governance Code:
Yes
—
Last update: April 2024